Robbie Hughes, Founder, and CEO, Lumeon
“Following the announcement of the Trump administration’s price transparency requirement – and the ensuing backlash from hospital groups – the issue of price transparency will dominate the healthcare industry next year. Regardless of the outcome of the lawsuit, I expect we’ll see more attention around the importance of the consumer (patient) experience and the notion that healthcare should become a shoppable, consumer-facing service. This shift will put pressure on providers to manage costs and predictability, and to figure out how to differentiate in a market where the patient will more choice upfront. It will also put pressure on payers to better coordinate the entire patient experience, from end-to-end.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Trip Hofer, Chief Executive Officer, AbleTo
“In 2020, the industry will realize that it’s not enough to only discuss access to mental health care. We need to be more specific about quality care. Providers need clinical criteria that are evidence-based and allow them to measure outcomes in a standard way, ensuring the care they deliver is actually working. Providers have improved the existing access to care, but often miss this crucial follow-up — What did the care do? What was accomplished? The emphasis on standards of quality and measurable outcomes will become a focal point.”
Source: HIT Consultant
